COMBODART

This brand name is authorized in Brazil, Estonia, France, Ireland, Lithuania, Malta, Mexico, Netherlands, UK.

Active ingredients

The drug COMBODART contains a combination of these active pharmaceutical ingredients (APIs):

1	Dutasteride UNII O0J6XJN02I - DUTASTERIDE
	Dutasteride reduces circulating levels of dihydrotestosterone (DHT) by inhibiting both type 1 and type 2, 5α-reductase isoenzymes which are responsible for the conversion of testosterone to DHT.
	Read more about Dutasteride
2	Tamsulosin UNII 11SV1951MR - TAMSULOSIN HYDROCHLORIDE
	Tamsulosin binds selectively and competitively to post-synaptic α1-adrenoreceptors, prevailingly their subtypes designated α1A and α1D. Thus relaxation of smooth muscles of the prostate and urethra is achieved, which leads to a reduction of tonus and an improvement of the urinary flow.
	Read more about Tamsulosin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
COMBODART Capsule, hard	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G04CA52	Tamsulosin and dutasteride	G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CA Alpha-adrenoreceptor antagonists
Discover more medicines within G04CA52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	510612050047805, 510612050047905, 510614040051505
EE	Ravimiamet	1390452, 1390463, 1390474
FR	Base de données publique des médicaments	65913639
GB	Medicines & Healthcare Products Regulatory Agency	171772, 373930, 381261
IE	Health Products Regulatory Authority	13905, 13987, 54351
LT	Valstybinė vaistų kontrolės tarnyba	1035097, 1055107, 1055108
MT	Medicines Authority	MA192/02601, PI1438/05701A, PI908/08101A, PI908/08101B
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	193M2012
NL	Z-Index G-Standaard, PRK	93661